DRUG STUDY

Generic Name Dosage, Classification Indications Mechanism Side Effects Nursing

(Brand Name) Timing and of Action Considerations

Route

(actual)

NAC -600mg Therapeutic Treatment of Exerts Respi: 1. Monitor

(Fluimucil) -OD @ HS Class: Mucolytic respiratory mucolytic Bronchospasm effectiveness of

Date Ordered: -PO Pharmacologic affections action through GI: Nausea, therapy and

1/25/18 Class: characterized its free vomiting advent of

Date Hepatoprotectiv by thick and sulfhydryl Hypersen: adverse/allergic

Discontinued: e agent viscous group which Urticaria, rash effects.

1/29/18 (glutathione hypersecretion opens up the Other: 2. Instruct

substitute) s disulfide Rhinorrhea patient in

bonds in the appropriate use

mucoproteins and adverse

thus lowering effects to report.

mucous 3. Perform
 viscosity. chest

physiotherapy

to loosen

secretions for

elimination

Enalapril -5mg Therapeutic Treatment of Competitively CNS: 1. Monitor

(Vasotec) -OD Class: hypertension inhibits ACE Headache, blood

DO:01-25-18 -PO Antihypertensive and prevention from dizziness, pressure

D/C: 1/29/18 Pharmacologic of heart failure converting fatigue, before

Class: and myocardial angiotensin I insomnia, and 30

ACE inhibitor infarction to angiotensin paresthesias minutes

II a potent CV: Syncope, after

vasoconstricto chest pain, administr

r. palpitations, ation

hypotension in 2. Avoid

salt- or volume- taking

depleted NSAIDS

patients 3. Instruct

GI: Gastric patient

irritation, not to

nausea, drink

vomiting, alcoholic

diarrhea, beverage

abdominal s

pain,

dyspepsia,

elevated liver

enzymes

GU:

Proteinuria,

renal

insufficiency,
 renal failure,

polyuria,

oliguria, urinary

frequency,

impotence

Hematologic:

Decreased

hematocrit and

hemoglobin

Other: Cough,

muscle

cramps,

hyperhidrosis

Carvedilol -6.25 mg tab Therapeutic Treatment of Competitively CNS: 1. Monitor

(Coreg) -BID Class: hypertension blocks alpha- Dizziness, blood

DO: 01-25-18 -PO Antihypertensive and treatment beta-& beta2 vertigo, pressure
D/C: 1/29/18 Pharmacologic for mild to adrenergic tinnitus, before and

class: Alpha- severe receptors and fatigue, after 30min.

and beta- congestive has some emotional of drug

adrenergic heart failure of sympathomim depression, administratio

blocker ischemic or etic activity at paresthesias, n.

cardiomyopathi beta sleep 2. Give with

c origin 2receptors disturbances food

thus CV: todecreaseo

contributing to Bradycardia, rthostatichyp

a decrease in orthostatic otension and

blood hypertension, adverse

pressure CHF, cardiac effects

arrhythmias, 3. Instruct for

pulmonary possible

edema, side effects

hypotension
GI: Gastric

pain,

flatulence,

constipation,

diarrhea,

hepatic failure

Respiratory:

Rhinitis,

pharyngitis,

dyspnea

Other: Fatigue,

back pain,

infections
Omeprazole -40mg Pharmacologic Treatment for Reduces CNS: 1. Tell

(Prilosec) -OD class: Proton GERD, Erosive Gastric Acid Headache, patient to take

DO: 01-25-18 -IVTT Pump Inhibitor Esophagitis Secretion and dizziness, 30-60 minutes

D/C:1/29/18 Therapeutic and short-term increases asthenia, before a meal,

class: Gastric treatment of Gastric mucus vertigo, preferably in

acid Secretion Duodenal ulcer, and insomnia, morning.

Inhibitor Gastric Ulcer, bicarbonate apathy, 2. Check

production, anxiety, for abdominal

creating paresthesias, pain, emesis,

protective dream diarrhea or

coating on abnormalities constipation.

gastric Dermatologic: 3.Evaluate

mucosa and Rash, fluid and

easing inflammation, intake

discomfort urticaria, 4. Watch for

from excess pruritus, elevated liver

gastric acid alopecia, dry function test

skin results

GI: Diarrhea, 5. Instruct

abdominal patient to

pain, nausea, swallow

vomiting, capsules or

constipation, tablets whole

dry mouth, and no to

tongue atrophy chew or crash

Respiratory: them.

URI symptoms,

cough,

epistaxis

Other: Cancer

in preclinical
 studies, back

pain, fever

Paracetamol -500mg Therapeutic Treatment Antipyretic: CNS: 1. Assess

(Biogesic) -PRN q4 (> class: Analgesic indicated for Reduces fever Headache patient’s

01-25-18 37.8C) ( Non- incidence of by acting CV: Chest temperature

-PO opioid)Antipyreti high fever directly on the pain, dyspnea, 2. Instruct to

c hypothalamic myocardial take the

Pharmacologic heat- damage when recommende

class: Para- regulating doses of 5–8 d dosage.

aminophenol center to g/day are 3. Assess

derivative cause ingested daily allergicreactio

vasodilation for several ns:

and sweating, weeks or when rash,urticaria;

which helps doses of 4 if these

dissipate heat. g/day are occur,drug

ingested for 1 may have to

yr be

GI: Hepatic discontinued

toxicity and

failure,

jaundice

GU: Acute

kidney failure,

renal tubular

necrosis

Hematologic:

Methemoglobin

emia—

cyanosis;

hemolytic

anemia—

hematuria,
 anuria;

neutropenia,

leukopenia,

pancytopenia,

thrombocytope

nia,

hypoglycemia

Hypersensitivi

ty: Rash, fever

Atorvastatin -40 mg Therapeutic Treatment Competitively CNS: 1.Stress that

(Lipitor) -OD @ HS class: indicated to inhibits HMG- Headache, atorvastatin is

DO: 01-25-18 -PO Dyslipidemic reduce total CoA asthenia an adjunct to

D/C: 1/28 agent cholesterol reductase, the GI: Flatulence, not a substitute

Pharmacologic level thus enzyme that abdominal for low-

class: HMG- reduction of catalyses the pain, cramps, cholesterol diet

CoA reductase risk of stroke conversion of constipation, 2.Tell patient to

 inhibitors and heart HMG-CoA to nausea, take drug at the

attack in type 2 mevalonic dyspepsia, same time each

diabetes acid. This heartburn, liver day to maintain

patients with results in the failure its effects

other CV risk induction of Respiratory: 3.Instruct

factors, the LDL Sinusitis, patient to take a

receptors, pharyngitis missed dose as

leading to Other: soon as

lowered LDL- Rhabdomyolysi possible. If it’s

cholesterol s with acute almost time

concentration. renal failure, for his next

arthralgia, dose, he should

myalgia skip the missed

dose

Budesonide -1 neb Therapeutic Treatment Have CNS: 1. Do not use

(Uceris) -q12 Class: Anti- indicated for potentanti- Headache, more often
DO:01-25-18 (may mix Inflammatory the inflammatory dizziness, than

D/C: 1/28/18 with Pharmacologic management of actions that lethargy, prescribed;

combivent) Class: Adrenal symptoms of reduces fatigue, do not stop

Glucocorticoid lower inflammation paresthesias, without

respiratory andhyper- nervousness consulting

infection reactivity(spas Dermatologic: your health

m) of the Rash, edema, care provider.

airways pruritus, 2. It may take

caused by alopecia several days

asthma Endocrine: to achieve

HPA good effects;

suppression, do not stop if

Cushing's effects are

syndrome with not

overdosage immediate.

and systemic 3. Use

absorption decongestant

GI: Nausea, nose drops

dyspepsia, dry first if nasal

mouth passages are

Local: Nasal blocked

irritation, fungal

infection

Respiratory:

Epistaxis,

rebound

congestion,

pharyngitis,

cough

Other: Chest

pain, asthenia,

moon face,
 acne, bruising,

back pain

Ipratropium -1 neb Therapeutic Management of Reduces CNS: 1. Take

sulfate + -q8 Class: reversible bronchospasm Headache, prescribed dose

Albuterol Bronchodilator bronchospasm through both restlessness, according to the

sulfate associated with anticholinergic vertigo, prescribed

(Combivent) Pharmacologic lower and drowsiness dosage

DO:01-25-18 class: respiratory sympathomim RESPI: 2. Advise to

D/C:1/28/18 Ipratropium infection etic Cough, perform chest

mechanisms. bronchospasm, physiotherapy

paradoxical after

airway nebulization to

resistance loosen

GI: nausea, secretions

vomiting, 2.Observe for

heartburn paradoxical
 CV: cardiac bronchospasm

arrhythmia, (Wheezing).

palpitations, 3.Notify

tachycardia physician or

SKIN: pallor, other healthcare

flushing, professional

sweating immediately if

severe

bronchospasm

occurs

Metoclopramid -1 amp Therapeutic Treatment Dopamine CNS: 1.instruct to

e -PRN for Class: indicated for antagonist that Depression( take as directed

(Reglan) vomiting Gastrointestinal gastroesophag acts by with suicidal may dilute

DO:01-25-18 -IVTT stimulant eal reflux increasing ideation), syrup in water,

disease (GERD) sensitivity to seizures, juice or

Pharmacologic acetylcholine; Hematologic: carbonated

 class: resultsincreas agranulocytosis drink.

Dopamine-2 e motility of , hypotension 2.Advise that

receptor the upper GI drug increases

antagonist. tract and movements or

relaxation of contractions

pyloric 3.Instruct to

sphincter and avoid alcohol

duodenal bulb and CNS

depressant

Hydrocortisone -50 mg Therapeutic Treatment Enters target CNS: Vertigo, 1. Inspect for

(Lycortis) -OD class: indicated cells and headache, any signs of

DO: 01-25-18 -IVTT Adrenocorticoid replacement binds to paresthesias, infection.

D/C: 1/26/18 replacement therapy in cytoplasmic insomnia, 2. . Use

Pharmacologic adrenal cortical receptor convulsions, minimal

class: insufficiency initiates many psychosis doses for

glucocorticoid, complex CV: minimal

mineralocorticoi reactions that Hypotension, duration to

d are shock, minimize

responsible for hypertension adverse

its anti- and CHF effects.

inflammatory secondary to 3. Taper doses

immunosuppr fluid retention, when

essive thromboemboli discontinuing

(glucocorticoid sm, high-dose or

), and salt- thrombophlebiti long-term

retaining s, fat therapy.

(mineralocortic embolism,

oid) actions. cardiac

arrhythmias

secondary to

electrolyte

disturbances
Dermatologic:

Thin, fragile

skin; petechiae;

ecchymoses;

purpura; striae;

subcutaneous

fat atrophy

EENT:

Cataracts,

glaucoma

(long-term

therapy),

increased IOP

Endocrine:

Amenorrhea,

irregular
menses,

growth

retardation,

decreased

carbohydrate

tolerance and

diabetes

mellitus,

cushingoid

state (long-

term therapy),

hypothalamic-

pituitary-

adrenal (HPA)

suppression

systemic with
therapy longer

than 5 days

GI: Peptic or

esophageal

ulcer,

pancreatitis,

abdominal

distension,

nausea,

vomiting,

increased

appetite and

weight gain

(long-term

therapy)

Hematologic:
Na+ and fluid

retention,

hypokalemia,

hypocalcemia,

increased

blood sugar,

increased

serum

cholesterol,

decreased

serum T1 and

T4 levels

Hypersensitivi

ty:

Anaphylactoid

or
hypersensitivity

reactions

Musculoskelet

al: Muscle

weakness,

steroid

myopathy and

loss of muscle

mass,

osteoporosis,

spontaneous

fractures (long-

term therapy)

Other:

Immunosuppre

ssion,
 aggravation or

masking of

infections,

impaired

wound healing

Meropenem -1 gm TC: Antibiotic Treatment Interferes with CNS: Fever, 1.Assess

(Merrem) -q8 PC: Beta- indicated for cell wall somnolence,sei patient for signs

DO: 01-25-18 -!V ANST Lactam infections replication of zures, and symptoms

D/C: 1/28/18 caused by susceptible dizziness,weak of infection

gram-positive organisms ness, ,including

or gram- ;osmotically headache,myo characteristics

negative unstable cell clia of wounds,

organisms walls wells sputum, urine,

and bursts stool

from osmotic 2.Complete C/S

pressure tests before

 beginning drug

therapy

3.Assess for

allergic

reactions,

anaphylaxis

Identify urine

output

4.Moniitor blood

studies

Febuxostat -40 mg TC: Antigout A xanthine Inhibits CNS: 1. Instruct

(Uloric) -OD PC: Xanthine oxidase (XO) conversion of Dizziness, patients to

DO:01-25-18 -PO oxidase inhibitor inhibitor hypoxanthine Hypersensitivit contact health

D/C: 1/28/18, indicated for to xanthine to y: Rash care provider if

2/15/18 the chronic uric acid; at GI: Nausea, they experience

management of therapeutic Abnormal chest pain,

hyperuricemia dosages, Musculoskelet rash, shortness

in patients with decreases al: Arthralgia of breath, or

gouty arthritis production of neurologic

uric acid symptoms

without suggesting a

disrupting stroke.

synthesis of 2. Advise

vital purines patients that

and product may be

pyrimidines taken without

regard to meals.

3.Advise patient

that

concomitant

prophylaxis with

an NSAID or
 colchicine for

gout flares may

be used

Amiodarone -200mg Therapeutic Treatment Shows beta CNS: Malaise, 1. Monitor

(Cordarone) -BID class: indicated for blocker-like fatigue, cardiac

DO:01-26-18 -PO Class III ventricular and potassium dizziness, rhythm

D/C: 1/29/18 Antiarrhythmic arrhythmias channel tremors, ataxia, continuousl

and atrial blocker-like paresthesias, y.

Pharmacologic fibrillation actions on the lack of

class: SA and AV coordination 2. Give drug

Benzofuran nodes, CV: Cardiac with meals

derivative increases the arrhythmias, to decrease

refractory CHF, cardiac GI

period via arrest, problems.

sodium- and

potassium- hypotension 3. Encourage

channel EENT: Corneal the patient

effects, and micro deposits to verbalize

slows intra- (photophobia, any

cardiac dry eyes, discomfort

conduction of halos, blurred since this

the cardiac vision); drug may

action ophthalmic have

potential, via abnormalities several

sodium- including adverse

channel permanent reaction

effects blindness

Endocrine:

Hypothyroidism

or

hyperthyroidis

m
GI: Nausea,

vomiting,

anorexia,

constipation,

abnormal liver

function tests,

liver toxicity

Respiratory:

Pulmonary

toxicity—

pneumonitis,

infiltrates

(shortness of

breath, cough,

rales,

wheezes)
 Other:

Photosensitivity

, angioedema

Levofloxacin -500mg Therapeutic Treatment Inhibits the CNS: 1. Take oral

(Levaquin) -q8 Class: Antibiotic indicated for enzyme DNA Headache, drug on an

DO:01-26-18 -IV amp acute bacterial gyrase dizziness, empty

D/C: 2/6/18 Pharmacologic infection in the insusceptible insomnia, stomach, 1

Class: lower gram-negative fatigue, hr before or

Fluoroquinolone respiratory and gram- somnolence, 2 hr after

system positive blurred vision meals. If an

aerobic and GI: Nausea, antacid is

anaerobic vomiting, dry needed, do

bacteria,interf mouth, not take it

ering with diarrhea, within 2 hr of

bacterial DNA abdominal pain levofloxacin

synthesis (occur less with dose.

this drug than 2. Drink plenty

with oflaxacin), of fluids

constipation, while you

flatulence are using

Hematologic: this drug.

Elevated BUN, 3. Take drug as

AST, ALT, prescribed

serum by the

creatinine, and physician..

alkaline

phosphatase;

neutropenia,

anemia

Other: Fever,

rash,

photosensitivity
 , muscle and

joint

tenderness

Donepezil -5mg 1 tab Therapeutic Treatment of Reversibly CNS: Abnormal 1. Advise

(Aricept) -OD @HS Class: Anti- Alzheimer’s inhibits gait, agitation, patient to take

DO:01-26-18 -PO alzheimers/Choli disease acetylcholinest anxiey, donepezil just

D/C: 2/12/18 nergics erase and asthenia, before going to

Pharmacologic improves depression,dizz bed.

Class: reversible acetylcholines iness, dream 2. Inform her

acetylcholineste concentration disturbances, that drug may

rase inhibitor at cholinergic fatigue, fever, be taken with or

synapses. headache,hosti without food.

Raising the lity, insomnia, 3. Instruct

acetylcholine nervousness, patient to avoid

level in the seizures, hazardous

cerebral somnolence, activities, such

cortex may syncope,tremor as driving, until

improve CV: Abnormal drugs CNS

cognition. ECG, effects are

Donepezil bradycardia, known.

becomes less chest pain, 4.Encourage to

effective as edema, heart take safety

Alzheimers failure, precautions to

disease hypertension, prevent falling if

progresses hypotension client

and the experiences

number of adverse

intact reactions, such

cholinergic as dizziness

neurons

declines
Lactulose -30cc Therapeutic Treatment Acidifies colon diarrhea

(Enulose) -OD @ HS class:: indicated for contents, 1.Effects are

DO:01-26-18 Gastrointestinal chronic osmotic effect seen in 24-48

D/C: agent, constipation of organic hrs

hyperosmotic acids causes 2.Do not self

laxative laxative action medicate with

another laxative

Pharmacologic because of slow

Class: Colonic onset

acidifier 3.Notify Dr if

diarrhea

persists for

more than 24

hrs, could be a

sign of

overdose, and
 need for med

adjustment

Potassium -1 tab TC: Alkalinizing To prevent Replace Arrhythmias, 1Make sure the

Chloride -TID Agents hypokalemia, potassium and Heart block, powder are

(K-Lyte) PC: Mineral and prophylaxis maintain Hypotension, completely

01-26-18 electrolyte during treatment potassium Cardiac arrest, dissolve before

replacements w/ diuretic level Hyperkalemia, giving

Respiratory 2.Monitor renal

paralysis, function after

GI: Nausea surgery, don’t

and vomiting give drug until

,abdominal urine flow is

pain established

3.Tell patient to

take drug with

or after meals
 with full glass of

water of fruit

juice to lessen

GI distress

Amlodipine -5 mg 1 tab Therapeutic Treatment of Block the CNS: 1. Monitor BP

(Norvasc) -OD Class: hypertension transport of Dizziness, for therapeutic

01-26-18 -PO Antihypertensive and prevention calcium into light- effectiveness.

of angina the headedness, BP reduction is

Pharmacologic resulting from smooth headache, greatest after

Class: Calcium coronary muscle cells asthenia, peak levels of

channel spasm. lining the fatigue, amlodipine are

blocker; coronary lethargy achieved 6-9 h

arteries and CV: Peripheral following oral

other edema, doses. Y

arteries of the arrhythmias 2. Monitor for

body Dermatologic: Signs

Flushing, rash &Symptoms of

GI: Nausea, dose-related

abdominal peripheral or

discomfort facial edema

that may not be

accompanied

by weight gain;

rarely, severe

edema may

cause

discontinuation

of drug. y

3. Monitor BP

with postural

changes.

Report postural
 hypotension.

4.Monitor more

frequently when

additional

antihypertensiv

es or diuretics

are added

Senekot -2 tabs Therapeutic Treatment Alters water GI: Cramping, 1.Assess bowel

(Senna) -STAT Class: Laxative indicated for and electrolyte diarrhea, function

01-29-18 -PO constipation transport in nausea, 2. Instruct client

Pharmacologic the large discoloration of for possible side

Class: Stimulant intestine urine effects

+ stool softener,

Anthraquinone

laxative
Diphenhydrami -25mg 1cap Therapeutic Treatment Significant CNS: 1. Monitor

ne -STAT Class: indicated for any anticholinergic dizziness; cardiovascular

(Benadryl) -pre BT Antihistamine allergic reactions activity. drowsiness; status

01-29-18 Competes for nervousness; especially with

Pharmacologic H restlessness; preexisting

Class: h1- 1-receptor trouble cardiovascular

receptor sites on sleeping; dry disease.

antagonist effector cells, mouth, nose, or 2. Monitor for

thus blocking throat; adverse effects

histamine GI: especially in

release. Constipation; older adult.

diarrhea; 3.Instruct to

excitability, take drug as

headache; loss indicated by the

of appetite; physician

nausea;
 vomiting

Furosemide -20mg Therapeutic Treatment Inhibits C NS: 1. Asses fluid

(Lasix) -IVTT Class: indicated for sodium and dizziness, status during

01-31-18 -STAT Cardiovascular edema due to chloride encephalopath therapy.

-Post BT agents cardiac reabsorption y, headache, 2. Monitor daily

disease. in the insomnia, weight, intake &

Pharmacologic ascending nervousness output ratios,

Class: Loop- loop of Henle, EENT: hearing amount and

Diuretics thus loss, tinnitus location of

increasing CV: edema, lung

renal excretion hypotension sounds, skin

of sodium, turgor, and

chloride and mucous

water membranes.

3.Monitor BP

and pulse
 before and

during

administration

4.Assess

patient for any

signs and

symptoms of

the adverse

effects

Vancomycin -1 gm Therapeutic Treatment Inhibiting the EENT: 1.Monitor blood

(Vancocin) (500mg in Class: indicated for second stage ototoxicity; pressure

02-04-18 100cc PNSS Glycopeptide lower of cell wall Hematologic: 2.Instruct for

for 2 cycles: antibiotics respiratory synthesis of hypotension; possible side

Total of 4 infection susceptible GI: nausea; effects

hours) Pharmacologic bacteria vomiting;

-q48 Class: Tricyclic eosinophilia;

 glycopeptide leukopenia;

phlebitis;

Musculoskelet

al: back and

neck pain;

hypersensitivi

ty:

anaphylaxis;

chills; fever;

Cefepime -2 gms TC: Antibiotics Treatment Fourth CNS: 1. Ask patient if

(Maxipime) -OD indicated for generation Fever,headach he is has

02-04-18 -IV drip x 1hr Pharmacologic moderate to cephalosporin e, allergies to

ANST Class: severe that inhibits Hematologic penicillin and

Cephalosporin community- bacterial cell :phlebitis cephalospiri

acquired wall synthesis, GI: nausea and n-2.Monitor

pneumonia promotes vomiting patient for

 osmotic superinfectio

instability, and n.

destroys 2. Take drug as

bacteria indicated by

the physician

Ketosteril -2 tabs Therapeutic Prevention and Normalizes Electrolytes: 1. Monitor

(Kyron -TID Class: treatment of metabolic hypercalcemia serum

Mthionine) -PO Ketoanalogs conditions process, calcium

DO: 02-08-18 caused by promotes levels.

DC: Pharmacologic modified or recycling 2. Instruct for

Class: Essential insufficient product possible

amino acids protein exchange.Red side effect

metabolism in uces ion 3. Take drug

chronic renal concentration as indicated

failure of potassium, by the

magnesium physician
 and

phosphate

Vitamin B -1 cap Therapeutic Treatment Act as co- CNS: 1.Instruct for

complex -OD Class: Food indicated to enzyme and Headache, possible side

(Nephrovite) -PO supplement prevent vitamin are essential dizziness, effects

DO:02-12-18 deficiency to the insomnia, 2.Monitor level

Pharmacologic metabolism of tiredness, of

Class: Water proteins fatigue, consciousness

soluble vitamins carbohydrates Hypersensitivi 3. take drugs as

and fatty acids ty: rash indicated by the

physician

Rebamipide -100mg Therapeutic Treatment Rebamipide is Hypersensitivi 1. Assess

(Remapride) -TID Class: Antacids indicated for a mucosal ty: Rash, for

DO: 02-13-18 -PO ulcer disease in protective pruritus, allergic

Pharmacologic the agent and GI: reactions

Class: gastro gastrointestinal ispostulated to constipation, 2. Monitor

 protectant tract increase diarrhea, dry bowel

quinolinone gastric blood mouth, dry function

derivative flow, lips,abdominal 3. Instruct

prostaglandinb distention, for side

iosynthesis constipation effects.

and decrease

free oxygen

radicals.

Prednisone -20 mg Therapeutic Replacement Enters target CNS: Vertigo, 1. Monitor vital

(Prednisolone) -BID Class: Anti- therapy in cells and headache, signs

02-14-18 -PO inflammatory, adrenal cortical binds to paresthesias, 2. Assess

immunosuppres insufficiency intracellular insomnia, level of

sant and short-term corticosteroid convulsions, consciousn

management of receptors, psychosis, ess

Pharmacologic various thereby cataracts, 3. Review

Class: inflammatory initiating increasedintrao laboratory

Adrenocorticoid and allergic manycomplex cular pressure, results

disorders reactions that glaucoma 4. Instruct for

are Hematologic: possible

responsible for Hypotension, side effects

its anti- shock, 5. Take drug

inflammatory hypertension as indicated

and and CHF by the

immunosuppr secondary to physician

essive effects fluid retention,

thromboemboli

sm,thrombophl

ebitis, fat

embolism,

cardiac

arrhythmias

Electrolytes:
Na+ and fluid

retention,

hypokalemia,

hypocalcemi